Clinical Trials Intensives

Palliative Care Intensives in Clinical Trials

Applications are no longer being accepted. Stay tuned for more Investigator Development activities.

This special one-time only three-day intensive will provide a foundation in practical aspects involving the conduct of randomized clinical trials in dementia palliative care. It is designed for early career researchers or other mid-career researchers and health professionals interested in developing competence in the planning, design, and execution of randomized clinical trials in persons with Alzheimer’s Disease or Related Dementias (ADRD). Instruction will include a combination of focused lectures, demonstrations, individual and group consultations with experts in the field, and small group work. 

The curriculum will enable participants to: 

• Describe the principles underlying the conduct of unbiased clinical trials.
• Identify the unique challenges posed by clinical trials conducted in persons with dementia (PWD) and their caregivers.
• Evaluate RCT designs in terms of their appropriateness for ADRD populations and their caregivers.
• Select appropriate strategies for enrollment, randomization, and retention.
• Understand methods for monitoring, coordinating, and conducting clinical trials in PWD and their caregivers.
• Develop basic strategies for appropriate statistical analyses.
• Design a dementia palliative care clinical trial with your working group.
• Better understand the process used in NIH Study Sections to review clinical trials. 
• Build community among palliative care researchers conducting research in populations with ADRD

Event Information: April 28-30, 2020, Washington-Duke Inn, Durham, North Carolina
Attendees may check into the hotel on April 27th

Cost: The cost of the program is supported by the PCRC: hotel reservations will be coordinated and paid for by the PCRC. Attendees will receive up to $700 to cover remaining travel-related expenses (economy airfare, meals per diem rate, and ground transportation). Expenses will be reimbursed after program completion. Expenses in excess of this amount or unallowable by NIH or MGH policy must be covered by the attendee.
 
If you have any questions regarding this opportunity, please address them to Naomi Gallopyn.